Market Place
Sourcing Support
CoreRx, Societal CDMO, Bend Bioscience Unite Under Bend Bioscience Brand
04 Sep 2024 //
PR NEWSWIRE
Owen Murray Named CEO Of Bend Bioscience, CoreRx And Societal Entities
08 Aug 2024 //
CONTRACT PHARMA
QHP Capital-Backed Entities Announce New CEO Appointment
07 Aug 2024 //
BUSINESSWIRE
CoreRx Completes Acquisition of Societal CDMO
09 Apr 2024 //
CONTRACTPHARMA
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
08 Apr 2024 //
GLOBENEWSWIRE
CoreRx moves to purchase Societal CDMO in $130M cash deal
29 Feb 2024 //
FIERCE PHARMA
CoreRx Appoints Dan Dobry as Chief Strategy Officer
24 Jul 2022 //
PRESS RELEASE
CoreRx Invests in Drug Development and Manufacturing Technologies and Capabilities
13 Jul 2022 //
PRESS RELEASE
CoreRx Scientific Leadership Team Adds Michael Grass, Ph.D.
01 Jun 2022 //
PRESS RELEASE
CoreRx Appoints Sitakant Chaudhury as Chief Financial Officer
09 May 2022 //
CONTRACTPHARMA
CoreRx Expands Product Development Team
11 Apr 2022 //
CONTRACTPHARMA
Pharma Nobis Acquires Fagron’s Contract Manufacturing Business and Facility
04 Feb 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.